Astellas Pharma Inc (OTCPK:ALPMF)
$ 11.095 -0.0325 (-0.29%) Market Cap: 19.93 Bil Enterprise Value: 24.15 Bil PE Ratio: 54.12 PB Ratio: 2.00 GF Score: 82/100

Astellas Pharma Inc Sustainability Meeting Transcript

Feb 17, 2023 / 05:00AM GMT
Release Date Price: $14.45
Hiromitsu Ikeda
Astellas Pharma Inc. - Corporate Head of Advocacy & Relations

Thank you very much for joining Astellas' Sustainability Meeting out of a very busy schedule today. I'm serving as MC. My name is Ikeda from Corporate Advocacy & Relations. Thank you for your time. (Operator Instructions) Thank you for your understanding.

Today, we have Dr. Kenji Yasukawa, Representative Director, President and CEO; Outside Director, Mamoru Sekiyama; Outside Director, Eriko Sakurai; Chief People Officer and Chief Ethics and Compliance Officer, Katsuyoshi Sugita; and Vice President, Head of Sustainability, Shingo Iino.

We are going to explain based on our meeting materials posted on our website. This material or presentation by representatives of the company under answers and statement in the Q&A session includes forward-looking statements based on assumptions and beliefs in light of the information currently available to management and subject to significant risks and uncertainties. Actual results may differ materially depending on a number of factors.

They contain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot